Global Dermatological Drugs Market 2014-2018

 Published On: Mar, 2014 |    No of Pages: 68 |  Published By: Technavio-Infiniti Research | Format: PDF
Request Free Sample

TechNavio's analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this marketís growth is an increase in the aging population worldwide. The Global Dermatological Drugs market has also been witnessing a spurt in the use of biologics. However, the risk of adverse side effects associated with dermatological drugs could pose a challenge to the growth of this market.

The Global Dermatological Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Dermatological Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include AbbVie Inc., Galderma S.A., Johnson & Johnson Ltd., Novartis AG, Stiefel Laboratories Inc., and Valeant Pharmaceuticals International Inc.

Other vendors mentioned in the report are Actavis plc, Allergan Inc., Almirall SA, Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol Myers Squibb Co., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., Genentech Inc., Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., Mylan Pharmaceuticals Inc., Pfizer Inc., and UCB SA.

Key questions answered in this report:
What will the market size and growth rate be in 2018?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Global Psoriasis Drugs Market
06.3.1 Market Size and Forecast
06.4 Global Acne Drugs Market
06.4.1 Market Size and Forecast
06.5 Global Dermatitis Drugs Market
06.5.1 Market Size and Forecast
06.6 Five Forces Analysis
07. Market Segmentation by Type
08. Geographical Segmentation
09. Buying Criteria
10. Rate of Incidence and Prevalence
Global Incidence and Prevalence of Psoriasis
Global Incidence and Prevalence of Acne
Global Incidence and Prevalence of Dermatitis
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbvie Inc.
18.1.1 Business Overview
18.1.2 Key Information
18.1.3 SWOT Analysis
18.2 Galderma S.A.
18.2.1 Business Overview
18.2.2 Key Information
18.2.3 SWOT Analysis
18.3 Johnson & Johnson Ltd.
18.3.1 Business Overview
18.3.2 Business Segmentation
18.3.3 Key Information
18.3.4 SWOT Analysis
18.4 Novartis International AG
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis
18.5 Stiefel Laboratories Inc.
18.5.1 Business Overview
18.5.2 Key Information
18.5.3 SWOT Analysis
18.6 Valeant Pharmaceuticals International Inc.
18.6.1 Business Overview
18.6.2 Business Segmentation
18.6.3 Key Information
18.6.4 SWOT Analysis
19. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Dermatological Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Psoriasis Drugs Market 2013-2018 (US$ billion)
Exhibit 4: Global Acne Drugs Market 2013-2018 (US$ billion)
Exhibit 5: Global Dermatitis Drugs Market 2013-2018 (US$ billion)
Exhibit 6: Global Dermatological Drugs Market by Segmentation (revenue)
Exhibit 7: Global Dermatological Drugs Market by Segmentation (percentage)
Exhibit 8: Comparison of YOY Growth Rates among various Market Segments in Global Dermatological Drugs Market
Exhibit 9: Global Dermatological Drugs Market Segmentation by Types
Exhibit 10: Global Dermatological Drugs Market by Type 2013 (in percent)
Exhibit 11: Global Dermatological Drugs Market by Geographical Segmentation 2013
Exhibit 12: Business Segmentation of Johnson & Johnson Ltd.
Exhibit 13: Business Segmentation of Novartis AG
Exhibit 14: Business Segmentation of Valeant Pharmaceuticals International Inc.

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.